Comparative Efficacy and Safety of Lorlatinib vs. Alectinib and Lorlatinib vs. Brigatinib for AlLK-Positive Advanced/Metastatic NSCLC: Matching-Adjusted Indirect Comparisons

Christine Garcia, Devin Abrahami,Anna Polli, Haitao Chu, Conor Chandler, Min Tan,John Mark Kelton, Despina Thomaiduo,Todd M. Bauer

crossref(2024)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要